Stock of the Day

Iterum Therapeutics (ITRM)

$1.50

+$0.01 (+0.3%)

Market Cap: $51.53M

About Iterum Therapeutics

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections.

The company was incorporated in 2015 and is headquartered in Dublin, Ireland.